HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamide

Also Known As:
AG 490; AG-490; AG490; n-benzyl-3,4-dihydroxy-benzylidenecyanoacetamide; tyrphostin AG-490; tyrphostin B42
Networked: 318 relevant articles (32 outcomes, 30 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Li, Hao-Nan: 4 articles (01/2022 - 01/2018)
2. Wang, Jun-Yang: 4 articles (01/2022 - 01/2018)
3. Wang, Ke: 4 articles (09/2018 - 01/2014)
4. Ivanovska, Nina: 4 articles (03/2015 - 11/2008)
5. Jiang, Tao: 4 articles (09/2014 - 12/2006)
6. Dong, Ning: 4 articles (03/2009 - 03/2003)
7. Yu, Yan: 4 articles (03/2009 - 03/2003)
8. Zeng, Xiao-Yan: 3 articles (01/2022 - 01/2018)
9. Zhang, Wei: 3 articles (01/2021 - 07/2010)
10. Wang, Dong: 3 articles (12/2020 - 04/2015)

Related Diseases

1. Inflammation (Inflammations)
2. Neoplasms (Cancer)
3. Infarction (Infarctions)
4. Autoimmune Diseases (Autoimmune Disease)
5. Brain Injuries (Brain Injury)

Related Drugs and Biologics

1. Tyrphostins
2. Proteins (Proteins, Gene)
3. Janus Kinases
4. Janus Kinase Inhibitors
5. 2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- one
6. Messenger RNA (mRNA)
7. Cytokines
8. Small Interfering RNA (siRNA)
9. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
10. Sirolimus (Rapamycin)

Related Therapies and Procedures

1. Aftercare (After-Treatment)
2. Ligation
3. Spinal Injections
4. Therapeutics
5. Punctures